Cargando…
High Efficiency of Low Dose Preparations of an Inactivated Lumpy Skin Disease Virus Vaccine Candidate
Capripox virus-induced diseases are commonly described as the most serious poxvirus diseases of production animals, as they have a significant impact on national and global economies. Therefore, they are classified as notifiable diseases under the guidelines of the World Organization for Animal Heal...
Autores principales: | Wolff, Janika, Beer, Martin, Hoffmann, Bernd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319008/ https://www.ncbi.nlm.nih.gov/pubmed/35891195 http://dx.doi.org/10.3390/vaccines10071029 |
Ejemplares similares
-
Development of a Safe and Highly Efficient Inactivated Vaccine Candidate against Lumpy Skin Disease Virus
por: Wolff, Janika, et al.
Publicado: (2020) -
Cross-Protection of an Inactivated and a Live-Attenuated Lumpy Skin Disease Virus Vaccine against Sheeppox Virus Infections in Sheep
por: Wolff, Janika, et al.
Publicado: (2023) -
Minimum Infective Dose of a Lumpy Skin Disease Virus Field Strain from North Macedonia
por: Wolff, Janika, et al.
Publicado: (2020) -
Review: Vaccines and Vaccination against Lumpy Skin Disease
por: Tuppurainen, Eeva, et al.
Publicado: (2021) -
Characterization of a Nigerian Lumpy Skin Disease Virus Isolate after Experimental Infection of Cattle
por: Wolff, Janika, et al.
Publicado: (2021)